Generation of recombinant Oropouche viruses lacking the nonstructural protein NSm or NSs

Journal of Virology

Volumn 90, Issue 5, 2016, Pages 2616-2627

  Tilston Lunel, Natasha L ^a,b   Acrani, Gustavo Olszanski ^a,c   Randall, Richard E ^b   Elliott, Richard M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; NSM PROTEIN; NSSPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; INTERFERON; VIRAL PROTEIN;

AEDES AEGYPTI; AEDES ALBOPICTUS; ANIMAL CELL; ARTICLE; BUNYAVIRIDAE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NONHUMAN; OROPOUCHE VIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DEFICIENCY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; ORTHOBUNYAVIRUS; PHYSIOLOGY; REVERSE GENETICS;

ANIMALS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERONS; ORTHOBUNYAVIRUS; REVERSE GENETICS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84961167427     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02849-15     Document Type: Article

References (68)

1. Elliott RM. 2014. Orthobunyaviruses: recent genetic and structural insights. Nat Rev Microbiol 12:673-685. http://dx.doi.org/10.1038/nrmicro3332.
2. Elliott RM, Brennan B. 2014. Emerging phleboviruses. Curr Opin Virol 5:50-57. http://dx.doi.org/10.1016/j.coviro.2014.01.011.
3. Nunes MR, Martins LC, Rodrigues SG, Chiang JO, Azevedo Rdo S, da Rosa AP, Vasconcelos PF. 2005. Oropouche virus isolation, southeast Brazil. Emerg Infect Dis 11:1610-1613. http://dx.doi.org/10.3201/eid1110.050464.
4. Dixon KE, Travassos da Rosa AP, Travassos da Rosa JF, Llewellyn CH. 1981. Oropouche virus. II. Epidemiological observations during an epidemic in Santarem, Para, Brazil in 1975. Am J Trop Med Hyg 30:161-164.
5. Pinheiro FP, Hoch AL, Gomes ML, Roberts DR. 1981. Oropouche virus. IV. Laboratory transmission by Culicoides paraensis. Am J Trop Med Hyg 30:172-176.
6. Vasconcelos HB, Azevedo RS, Casseb SM, Nunes-Neto JP, Chiang JO, Cantuaria PC, Segura MN, Martins LC, Monteiro HA, Rodrigues SG, Nunes MR, Vasconcelos PF. 2009. Oropouche fever epidemic in Northern Brazil: epidemiology and molecular characterization of isolates. J Clin Virol 44:129-133. http://dx.doi.org/10.1016/j.jcv.2008.11.006.
7. Baisley KJ, Watts DM, Munstermann LE, Wilson ML. 1998. Epidemi-ology of endemic Oropouche virus transmission in upper Amazonian Peru. Am J Trop Med Hyg 59:710-716.
8. Mourao MP, Bastos MS, Gimaqu JB, Mota BR, Souza GS, Grimmer GH, Galusso ES, Arruda E, Figueiredo LT. 2009. Oropouche fever outbreak, Manaus, Brazil, 2007-2008. Emerg Infect Dis 15:2063-2064. http://dx.doi.org/10.3201/eid1512.090917.
9. Bastos Mde S, Figueiredo LT, Naveca FG, Monte RL, Lessa N, Pinto de Figueiredo RM, Gimaque JB, Pivoto Joao G, Ramasawmy R, Mourao MP. 2012. Identification of Oropouche Orthobunyavirus in the cerebrospinal fluid of three patients in the Amazonas, Brazil.AmJ Trop Med Hyg 86:732-735. http://dx.doi.org/10.4269/ajtmh.2012.11-0485.
10. Pinheiro FP, Travassos da Rosa AP, Travassos da Rosa JF, Bensabath G. 1976. An outbreak of Oropouche virus disease in the vicinity of Santarem, Para, Brazil. Tropenmed Parasitol 27:213-223.
11. Pinheiro FP, Travassos da Rosa AP, Gomes ML, LeDuc JW, Hoch AL. 1982. Transmission of Oropouche virus from man to hamster by the midge Culicoides paraensis. Science 215:1251-1253. http://dx.doi.org/10.1126/science.6800036.
12. Roberts DR, Hoch AL, Dixon KE, Llewellyn CH. 1981. Oropouche virus. III. Entomological observations from three epidemics in Para, Brazil, 1975. Am J Trop Med Hyg 30:165-171.
13. Anderson CR, Spence L, Downs WG, Aitken TH. 1961. Oropouche virus: a new human disease agent from Trinidad, West Indies. Am J Trop Med Hyg 10:574-578.
14. Pinheiro FP, Travassos da Rosa AP, Travassos da Rosa JF, Ishak R, Freitas RB, Gomes ML, LeDuc JW, Oliva OF. 1981. Oropouche virus. I. A review of clinical, epidemiological, and ecological findings. Am J Trop Med Hyg 30:149-160.
15. Roberts DR, Pinheiro FDPP, Hoch AL, LeDuc JW, Peterson NE, Santos MAV, Western KA. 1977. Vectors and natural reservoirs of Oropouche virus in the Amazon region. US Army Medical Research and Development Command, Washington, DC.
16. Smith GC, Francy DB. 1991. Laboratory studies of a Brazilian strain of Aedes albopictus as a potential vector of Mayaro and Oropouche viruses. J Am Mosquito Control Assoc 7:89-93.
17. Pinheiro FP, Pinheiro M, Bensabath G, Causey OR, Shope RE. 1962. Epidemia de vírus Oropouche em Belém. Revista do Serv Especial Saude 12:15-23.
18. Pinheiro FP, Travassos da Rosa AP, Vasconcelos PF. 2004. Bunyaviridae: other Bunyaviridae. Oropouche fever, p 2418-2423. In Feigin RD, Cherry J, Demmler GJ, Kaplan SL (ed), Textbook of pediatric infectious diseases, 5th ed. Saunders, Philadelphia, PA.
19. Watts DM, Phillips I, Callahan JD, Griebenow W, Hyams KC, Hayes CG. 1997. Oropouche virus transmission in the Amazon River basin of Peru. Am J Trop Med Hyg 56:148-152.
20. Mercer DR, Castillo-Pizango MJ. 2005. Changes in relative species compositions of biting midges (Diptera: Ceratopogonidae) and an outbreak of Oropouche virus in Iquitos, Peru. J Med Entomol 42:554-558. http://dx.doi.org/10.1093/jmedent/42.4.554.
21. Rosa AP, Rodrigues SG, Nunes MR, Magalhaes MT, Rosa JF, Vasconcelos PF. 1996. Outbreak of oropouche virus fever in Serra Pelada, municipality of Curionopolis, Para, 1994. Rev Soc Bras Med Trop 29:537-541. (In Portuguese.).
22. Pan American Health Organization. 2010. Epidemiological alert. Outbreak of Oropouche fever. Pan American Health Organization, Washington, DC. http://www1.paho.org/hq/dmdocuments/2010/epi_alert_2010_22_June_Oropouche_Fever.pdf.
23. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, Vallejo E, Madrid C, Aguayo N, Gotuzzo E, Suarez V, Morales AM, Beingolea L, Reyes N, Perez J, Negrete M, Rocha C, Morrison AC, Russell KL, Blair JP, Olson JG, Kochel TJ. 2010. Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis 4:e787.
24. Tilston-Lunel NL, Hughes J, Acrani GO, da Silva DE, Azevedo RS, Rodrigues SG, Vasconcelos PF, Nunes MR, Elliott RM. 2015. Genetic analysis of members of the species Oropouche virus and identification of a novel M segment sequence. J Gen Virol 96:1636-1650. http://dx.doi.org/10.1099/vir.0.000108.
25. Aguilar PV, Barrett AD, Saeed MF, Watts DM, Russell K, Guevara C, Ampuero JS, Suarez L, Cespedes M, Montgomery JM, Halsey ES, Kochel TJ. 2011. Iquitos virus: a novel reassortant orthobunyavirus associated with human illness in Peru. PLoS Negl Trop Dis 5:e1315. http://dx.doi.org/10.1371/journal.pntd.0001315.
26. Ladner JT, Savji N, Lofts L, Travassos da Rosa A, Wiley MR, Gestole MC, Rosen GE, Guzman H, Vasconcelos PF, Nunes MR, Lipkin WI, Tesh RB, Palacios G. 2014. Genomic and phylogenetic characterization of viruses included in the Manzanilla and Oropouche species complexes of the genus Orthobunyavirus, family Bunyaviridae. J Gen Virol 95:1055-1066. http://dx.doi.org/10.1099/vir.0.061309-0.
27. Acrani GO, Tilston-Lunel NL, Spiegel M, Weidemann M, Dilcher M, da Silva DE, Nunes MR, Elliott RM. 2014. Establishment of a minigenome system for Oropouche virus reveals the S genome segment to be significantly longer than reported previously. J Gen Virol 95:513-523.
28. Bridgen A, Elliott RM. 1996. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc Natl Acad Sci U S A 93:15400-15404.
29. Buchholz UJ, Finke S, Conzelmann KK. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251-259.
30. Shi X, Elliott RM. 2009. Generation and analysis of recombinant Bunyamwera orthobunyaviruses expressing V5 epitope-tagged L proteins. J Gen Virol 90:297-306. http://dx.doi.org/10.1099/vir.0.007567-0.
31. Johnson KN, Zeddam JL, Ball LA. 2000. Characterization and construction of functional cDNA clones of Pariacoto virus, the first Alphanodavirus isolated outside Australasia. J Virol 74:5123-5132. http://dx.doi.org/10.1128/JVI.74.11.5123-5132.2000.
32. Elliott RM, Blakqori G, van Knippenberg IC, Koudriakova E, Li P, McLees A, Shi X, Szemiel AM. 2013. Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe. J Gen Virol 94:851-859. http://dx.doi.org/10.1099/vir.0.049981-0.
33. Brennan B, Welch SR, Elliott RM. 2014. The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging. PLoS Pathog 10:e1003922. http://dx.doi.org/10.1371/journal.ppat.1003922.
34. Emeny JM, Morgan MJ. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol 43:247-252.
35. Chinsangaram J, Piccone ME, Grubman MJ. 1999. Ability of foot-andmouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 73:9891-9898.
36. Desmyter J, Melnick JL, Rawls WE. 1968. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2:955-961.
37. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363-4369. http://dx.doi.org/10.1128/JVI.78.8.4363-4369.2004.
38. van Knippenberg I, Carlton-Smith C, Elliott RM. 2010. The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. J Gen Virol 91:2002-2006. http://dx.doi.org/10.1099/vir.0.021774-0.
39. Killip MJ, Young DF, Gatherer D, Ross CS, Short JA, Davison AJ, Goodbourn S, Randall RE. 2013. Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J Virol 87:4798-4807. http://dx.doi.org/10.1128/JVI.03383-12.
40. Bridgen A, Weber F, Fazakerley JK, Elliott RM. 2001. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci U S A 98:664-669. http://dx.doi.org/10.1073/pnas.98.2.664.
41. Hart TJ, Kohl A, Elliott RM. 2009. Role of the NSs protein in the zoonotic capacity of Orthobunyaviruses. Zoonoses Public Health 56:285-296. http://dx.doi.org/10.1111/j.1863-2378.2008.01166.x.
42. Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, Jackson D, Elliott RM, Randall RE. 2009. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 383: 6-11. http://dx.doi.org/10.1016/j.virol.2008.10.002.
43. Streitenfeld H, Boyd A, Fazakerley JK, Bridgen A, Elliott RM, Weber F. 2003. Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J Virol 77:5507-5511. http://dx.doi.org/10.1128/JVI.77.9.5507-5511.2003.
44. Varela M, Schnettler E, Caporale M, Murgia C, Barry G, McFarlane M, McGregor E, Piras IM, Shaw A, Lamm C, Janowicz A, Beer M, Glass M, Herder V, Hahn K, Baumgartner W, Kohl A, Palmarini M. 2013. Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog 9:e1003133. http://dx.doi.org/10.1371/journal.ppat.1003133.
45. Figueiredo LT, Da Rosa AP. 1988. Jatobal virus antigenic characterization by ELISA and neutralization test using EIA as indicator, on tissue culture. Mem Inst Oswaldo Cruz 83:161-164.
46. Shi X, Kohl A, Leonard VH, Li P, McLees A, Elliott RM. 2006. Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J Virol 80:8089-8099. http://dx.doi.org/10.1128/JVI.00579-06.
47. Shi X, Kohl A, Li P, Elliott RM. 2007. Role of the cytoplasmic tail domains of Bunyamwera orthobunyavirus glycoproteins Gn and Gc in virus assembly and morphogenesis. J Virol 81:10151-10160. http://dx.doi.org/10.1128/JVI.00573-07.
48. Kading RC, Crabtree MB, Bird BH, Nichol ST, Erickson BR, Horiuchi K, Biggerstaff BJ, Miller BR. 2014. Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl Trop Dis 8:e2670. http://dx.doi.org/10.1371/journal.pntd.0002670.
49. Crabtree MB, Kent Crockett RJ, Bird BH, Nichol ST, Erickson BR, Biggerstaff BJ, Horiuchi K, Miller BR. 2012. Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis 6:e1639. http://dx.doi.org/10.1371/journal.pntd.0001639.
50. Soellick T, Uhrig JF, Bucher GL, Kellmann JW, Schreier PH. 2000. The movement protein NSm of tomato spotted wilt tospovirus (TSWV): RNA binding, interaction with the TSWV N protein, and identification of interacting plant proteins. Proc Natl Acad SciUSA97:2373-2378. http://dx.doi.org/10.1073/pnas.030548397.
51. Kormelink R, Storms M, Van Lent J, Peters D, Goldbach R. 1994. Expression and subcellular location of the NSM protein of tomato spotted wilt virus (TSWV), a putative viral movement protein. Virology 200:56-65.
52. Storms MM, Kormelink R, Peters D, Van Lent JW, Goldbach RW. 1995. The nonstructuralNSmprotein of tomato spotted wilt virus induces tubular structures in plant and insect cells. Virology 214:485-493.
53. Weber F, Bridgen A, Fazakerley JK, Streitenfeld H, Kessler N, Randall RE, Elliott RM. 2002. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949-7955. http://dx.doi.org/10.1128/JVI.76.16.7949-7955.2002.
54. Kohl A, Clayton RF, Weber F, Bridgen A, Randall RE, Elliott RM. 2003. Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol 77:7999-8008. http://dx.doi.org/10.1128/JVI.77.14.7999-8008.2003.
55. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. 2004. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798-9806. http://dx.doi.org/10.1128/JVI.78.18.9798-9806.2004.
56. Léonard VH, Kohl A, Hart TJ, Elliott RM. 2006. Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol 80:9667-9675. http://dx.doi.org/10.1128/JVI.00822-06.
57. Eick D, Geyer M. 2013. The RNA polymerase II carboxy-terminal domain (CTD) code. Chem Rev 113:8456-8490. http://dx.doi.org/10.1021/cr400071f.
58. Corden JL. 2013. RNA polymerase II C-terminal domain: tethering transcription to transcript and template. Chem Rev 113:8423-8455. http://dx.doi.org/10.1021/cr400158h.
59. Robinson PJJ, Bushnell DA, Trnka MJ, Burlingame AL, Kornberg RD. 2012. Structure of the Mediator Head module bound to the carboxyterminal domain of RNA polymerase II. Proc Natl Acad Sci U S A 109: 17931-17935. http://dx.doi.org/10.1073/pnas.1215241109.
60. Thomas D, Blakqori G, Wagner V, Banholzer M, Kessler N, Elliott RM, Haller O, Weber F. 2004. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279:31471-31477. http://dx.doi.org/10.1074/jbc.M400938200.
61. Verbruggen P, Ruf M, Blakqori G, Overby AK, Heidemann M, Eick D, Weber F. 2011. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem 286:3681-3692. http://dx.doi.org/10.1074/jbc.M110.154799.
62. Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, Weiss S, Michiels T, Staeheli P, Weber F. 2007. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 81:4991-4999. http://dx.doi.org/10.1128/JVI.01933-06.
63. Barry G, Varela M, Ratinier M, Blomstrom AL, Caporale M, Seehusen F, Hahn K, Schnettler E, Baumgartner W, Kohl A, Palmarini M. 2014. NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery. J Gen Virol 95:1640-1646. http://dx.doi.org/10.1099/vir.0.065425-0.
64. Assfalg R, Lebedev A, Gonzalez OG, Schelling A, Koch S, Iben S. 2012. TFIIH is an elongation factor of RNA polymerase I. Nucleic Acids Res 40:650-659. http://dx.doi.org/10.1093/nar/gkr746.
65. Ning YJ, Feng K, Min YQ, Cao WC, Wang M, Deng F, Hu Z, Wang H. 2015. Disruption of type I interferon signaling by NSs protein of severe fever with thrombocytopenia syndrome virus via hijacking STAT2 and STAT1 into inclusion bodies. J Virol 89:4227-4236. http://dx.doi.org/10.1128/JVI.00154-15.
66. Ning YJ, Wang M, Deng M, Shen S, Liu W, Cao WC, Deng F, Wang YY, Hu Z, Wang H. 2014. Viral suppression of innate immunity via spatial isolation of TBK1/IKKepsilon from mitochondrial antiviral platform. J Mol Cell Biol 6:324-337. http://dx.doi.org/10.1093/jmcb/mju015.
67. Proenca-Modena JL, Sesti-Costa R, Pinto AK, Richner JM, Lazear HM, Lucas T, Hyde JL, Diamond MS. 2015. Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and type I interferon signaling pathways in nonmyeloid cells. J Virol 89:4720-4737. http://dx.doi.org/10.1128/JVI.00077-15.
68. Livonesi MC, de Sousa RL, Badra SJ, Figueiredo LT. 2007. In vitro and in vivo studies of the interferon-alpha action on distinct Orthobunyavirus. Antiviral Res 75:121-128. http://dx.doi.org/10.1016/j.antiviral.2007.01.158.